In the current scenario, treatment of Post Kala Azar Dermal leishmaniasis (PKDL) is intravenous liposomal amphotericin B or oral miltefosine. Over the years, there has been a gradual decline in efficacy of miltefosine and a rise in permanent loss of vision. Mo... ...

请注册登录后继续浏览